The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001379110.1(SLC9A6):c.517G>A (p.Val173Ile)

CA10524682

512592 (ClinVar)

Gene: SLC9A6
Condition: Christianson syndrome
Inheritance Mode: X-linked inheritance
UUID: 8392c0c2-b085-4ae9-9c28-847604704552
Approved on: 2024-02-23
Published on: 2024-03-31

HGVS expressions

NM_001379110.1:c.517G>A
NM_001379110.1(SLC9A6):c.517G>A (p.Val173Ile)
NC_000023.11:g.135998551G>A
CM000685.2:g.135998551G>A
NC_000023.10:g.135080710G>A
CM000685.1:g.135080710G>A
NC_000023.9:g.134908376G>A
NG_017160.1:g.18125G>A
ENST00000370695.8:c.673G>A
ENST00000370701.6:c.517G>A
ENST00000630721.3:c.517G>A
ENST00000636092.1:c.517G>A
ENST00000636347.1:c.517G>A
ENST00000637195.1:c.421G>A
ENST00000637234.1:c.517G>A
ENST00000637581.1:c.517G>A
ENST00000643775.1:n.460G>A
ENST00000674809.1:c.460G>A
ENST00000675550.1:n.458G>A
ENST00000675856.1:n.460G>A
ENST00000676043.1:c.460G>A
ENST00000678163.1:c.673G>A
ENST00000370695.6:c.673G>A
ENST00000370698.7:c.577G>A
ENST00000370701.5:c.517G>A
ENST00000627534.2:c.517G>A
NM_001042537.1:c.673G>A
NM_001177651.1:c.517G>A
NM_006359.2:c.577G>A
NM_001330652.1:c.421G>A
NM_001177651.2:c.517G>A
NM_001330652.2:c.421G>A
NM_006359.3:c.577G>A
NM_001042537.2:c.673G>A
NM_001400909.1:c.517G>A
NM_001400910.1:c.517G>A
NM_001400911.1:c.517G>A
NM_001400912.1:c.517G>A
NM_001400913.1:c.421G>A
More

Likely Benign

Met criteria codes 4
BS1 BP5 BP4 BS2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SLC9A6 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Val193Ile variant in SLC9A6 (NM_006359.2) is 0.008% in South Asian sub population in gnomAD v4, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Val193Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Val193Ile variant is observed in the hemizygous state in at least 1 unaffected individuals (internal database - GeneDx) (BS2_supporting). The p.Val193Ile variant is found in a patient with an alternate molecular basis of disease (internal database - GeneDx) (BP5). In summary, the p.Val193Ile variant in SLC9A6 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4, BS2_supporting, BP5).
Met criteria codes
BS1
The allele frequency of the p.Val193Ile variant in SLC9A6 (NM_006359.2) is 0.008% in South Asian sub population in gnomAD v4, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1).
BP5
The p.Val193Ile variant is found in a patient with an alternate molecular basis of disease (internal database - GeneDx) (BP5).
BP4
Computational analysis prediction tools suggest that the p.Val193Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4).
BS2_Supporting
The p.Val193Ile variant is observed in the hemizygous state in at least 1 unaffected individuals (internal database - GeneDx) (BS2_supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.